Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Carrier (CARR) is levered to a structural surge in data-center cooling and appears to be entering a short-cycle operational recovery. At $55.57 today the stock offers a tradeable asymmetric return: continued backlog-led order growth and cash generation justify a target near $66.50 while near-term weakness below $50 should force an exit. Technicals …
Adaptive Biotechnologies highlights the new international consensus definition of cure for multiple myeloma, which places highly sensitive measurable residual disease (MRD) negativity at its core, as announced at the International Myeloma Society meeting. The definition requires sustained MRD negativity assessed by next-generation sequencing or flo…
Nutriband Inc., a US-based biotech company developing abuse-deterrent transdermal pharmaceutical products, has appointed Robert J. O'Neill, a highly decorated former Navy SEAL and veterans health advocate, to its Advisory Board. O'Neill's extensive leadership experience and advocacy for veterans' health align with Nutriband's mission as the company…
Navient has appointed Diane Offereins, a seasoned executive with over 35 years in financial services and expertise in executive compensation, IT, and cybersecurity, to its board of directors effective September 24, 2026. This strategic addition follows the retirement of a board member earlier in June 2026 and is expected to enhance the company’s le…
CoreCivic announces the appointment of Lucibeth N. Mayberry as President, CEO, and Board Director after Patrick D. Swindle resigns due to stage four metastatic pancreatic cancer. The leadership transition is endorsed by the Board, emphasizing continuity in the company’s strategic direction and operational focus.
NANO Nuclear Energy Inc., alongside IP3 Corporation and Cybernetic Intelligence, signed a Letter of Intent to jointly explore nuclear-powered artificial intelligence and critical infrastructure projects in the U.S. and select international markets. The collaboration names NANO Nuclear as the preferred nuclear technology provider, combining expertis…
Alpha Compute Corp., a provider of AI compute infrastructure and GPU services, announced it has regained compliance with Nasdaq Listing Rules by meeting the minimum closing bid price requirement of $1.00 per share. This marks the resolution of the prior deficiency noted in March 2026 and reflects ongoing efforts to strengthen the company and delive…
Firefly Neuroscience (NASDAQ: AIFF) announced a strategic partnership with NeuroSigma to broaden clinician access to NeuroSigma’s Monarch eTNS® System, the first FDA-cleared non-drug treatment for pediatric ADHD. The partnership integrates Firefly’s AI-powered Evoke™ brain assessment platform with Monarch’s at-home external trigeminal nerve stimula…
Cipher Digital announced a lease extension at its Barber Lake data center in Texas from 10 to 20 years, increasing contracted revenue from $3.8 billion to over $9 billion. The extension includes a new 10-year lease with a leading AI lab, reflecting strong demand for hyperscale computing capacity. The phased delivery of data halls is on schedule, wi…
Cerenome, Inc., a CNS oncology company, announced a conference call on September 30, 2026, to provide updates on its CNSide® cerebrospinal fluid diagnostic platform. The update will highlight recent progress in commercial activities including third-party billing, market access, expansion of the commercial team, and testing portfolio growth. Cerenom…
X-energy announced the planned retirement of Joel Duling as president of TRISO-X, its nuclear fuels subsidiary, effective November 20, 2026. Duling will transition to a senior advisory role while interim leadership takes over and the company searches for a permanent successor. The firm continues to progress on the construction of the TX-1 advanced …
Quantum Cyber N.V. announced a strategic repositioning emphasizing its AI-powered quantum antenna technology and autonomous drones designed for GPS-denied warfare environments. The company is narrowing its focus to three core product pillars and accelerating U.S.-based manufacturing with a new facility in Connecticut, complemented by favorable U.S.…
ASE Technology (ASX) sits at the center of the AI-driven shortage in advanced packaging capacity. With valuation stretched versus historical ranges but fundamentals and technicals supportive, this trade idea targets an entry on a mild pullback and a mid-term hold as LEAP and other capacity expansions ramp.
FedEx (FDX) has been punished aggressively, leaving the stock trading at ~$280 with a P/E ~15 and free cash flow of roughly $5.1B. Technicals show deep oversold readings and elevated short activity. The market appears to be pricing in a clean FedEx Freight quarter that the company has not consistently produced. We see a tactical, risk-managed long:…
Edible Garden AG Incorporated announced it has secured a third Walmart distribution center for its fresh herb products, expanding its presence across the Eastern Midwest. This award enhances its regional retail reach, improves supply chain efficiency, and supports growth into higher-margin food and nutrition products. The company continues to lever…
Ocugen, Inc. announced that its investigational gene therapy OCU400 has received provisional approval and priority designation from the Longevity and Regenerative Therapies Board in The Bahamas. This approval enables Ocugen to offer OCU400 through an expanded access program with plans to treat the first patient within 90 days post full approval. OC…
C4 Therapeutics (Nasdaq: CCCC) presented encouraging biomarker data from their Phase 1 trial of cemsidomide with dexamethasone and Phase 1b trial combining cemsidomide with elranatamab in relapsed/refractory multiple myeloma patients. The data showed robust T-cell activation, enhanced immune response, and safety at initial dose levels, supporting c…
FactSet has appointed Marcel Prins, an experienced leader in operations, technology, and asset management, to its Board of Directors. Prins's background in digital transformation and data governance at major European asset managers is expected to enhance FactSet's strategic initiatives in AI and financial intelligence solutions.
Fate Therapeutics announced a $15 million grant award from the California Institute for Regenerative Medicine (CIRM) to support its Phase 2 RECLAIM-LN trial, investigating FT819, an off-the-shelf CAR T-cell therapy for patients with refractory moderate-to-severe lupus nephritis. The therapy aims to offer durable B cell depletion, potentially improv…
Reborn Coffee, Inc. has signed a non-binding Memorandum of Understanding with Visvita, a beverage and distribution company, to leverage Visvita’s US and Mexico distribution infrastructure for expanding Reborn's global franchise supply chain and launching a co-branded ready-to-drink (RTD) beverage lineup. The partnership aims to improve supply chain…
Legend Biotech Corp. reported five-year follow-up results from the CARTITUDE-2 study cohort A demonstrating that 50% of patients with relapsed/refractory multiple myeloma (RRMM) treated with a single infusion of CARVYKTI (ciltacabtagene autoleucel) remain alive and progression-free without maintenance therapy. The data reinforce the potential curat…
Rocket Lab has locked financing and is pushing to close its acquisition of Iridium. The strategic fit - instant scale, recurring government and enterprise cash flows, and Iridium's global L-band network - creates a credible willingness to pay up. For traders, IRDM offers a defined, event-driven long opportunity with asymmetric upside if the deal or…
Solid Biosciences (SLDB) presents a high-conviction long trade at $7.48. The company has rebuilt balance-sheet resilience, broadened capsid licensing and program exposure, and is positioned to capture upside as Duchenne screening, regulatory designations and partnerships compress risk. Entry $7.48, target $11.45, stop $5.50. Time horizon: long term…
High-level diplomacy at the United Nations and a state visit to Washington yielded scant breakthroughs this week, leaving markets to react to developments in energy flows, elevated fuel costs and signs of persistent inflation. A sharp rise in yields in the US, Japan and elsewhere dominated market moves as crude prices oscillated on thin hopes for a…
Sendas (ASAIY) finished a multiyear expansion of its low-cost Assaí chain and is trading near the top of its 52-week range at $9.72. With a $2.63B market cap, a trailing P/E of 14.4 and improving technicals, the risk/reward favors a long bias. This trade idea offers a clear entry at $9.72, stop at $8.50 and target at $12.50 over a long-term (180 tr…
